Administration of irisin is expected to protect against MI/R‐induced cardiac dysfunction via MITOL‐mediated ER stress and apoptosis inhibition, thus ultimately preserving cardiac function (Figure 5). This evidence concerns the gene FNDC5 and myocardial infarction.